| Shemesh Shay |
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2024-05-10 |
$6.32 |
-2.5% |
1,113
|
$7,034 |
| Shemesh Shay |
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-21 |
$11.99 |
-48.6% |
420
|
$5,036 |
| Shemesh Shay |
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-15 |
$10.71 |
-42.5% |
670
|
$7,176 |
| Shemesh Shay |
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2022-12-21 |
$7.65 |
-19.5% |
500
|
$3,825 |
| Shemesh Shay |
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-11-17 |
$7.15 |
-13.8% |
300
|
$2,145 |
| Shemesh Shay |
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-23 |
$7.87 |
-21.7% |
220
|
$1,731 |
| Shemesh Shay |
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-02 |
$8.31 |
-25.9% |
404
|
$3,357 |
| Shemesh Shay |
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-01 |
$8.07 |
-23.7% |
3,006
|
$24,258 |
| Shemesh Shay |
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-20 |
$16.54 |
-62.8% |
300
|
$4,962 |
| Shemesh Shay |
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-17 |
$19.44 |
-68.3% |
242
|
$4,704 |
| Shemesh Shay |
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-12 |
$15.85 |
-61.1% |
1,278
|
$20,255 |
| Shemesh Shay |
Chief Development Officer |
Nuvectis Pharma, Inc. (NVCT)
|
2022-02-07 |
$3.41 |
80.9% |
2,946
|
$10,034 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-25.7% |
$-24,299 |
$94,517 |